Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

Blood (2012) 119 (25): 6109–6117.

https://doi.org/10.1182/blood-2011-12-397620

Published: 2012

Includes: Supplemental data

Journal Articles

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

Hideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, Anna M. Jankowska, Sarah Abu Kar, Andres Jerez, Bartlomiej Przychodzen, Manoj Bupathi, Kathryn Guinta, Manuel G. Afable, Mikkael A. Sekeres, Richard A. Padgett, Ramon V. Tiu, Jaroslaw P. Maciejewski

Blood (2012) 119 (14): 3203–3210.

https://doi.org/10.1182/blood-2011-12-399774

Published: 2012

Includes: Supplemental data

Journal Articles

Defining the Topography of Deletion 5q Using SNP-A Identifies Patients with More Aggressive Disease and Correlates with Additional Lesions

Andres Jerez, MD, Anna M Jankowska, PhD, Hideki Makishima, MD, Lukasz P Gondek, MD, Ramon V Tiu, MD, Christine L O‘Keefe, PhD, Azim M Mohamedali, PhD, Denise Batista, PhD, Michael A McDevitt, MD, PhD, Mikkael A Sekeres, MD, Ghulam J. Mufti, MD, Jaroslaw P Maciejewski, MD, PhD

Blood (2011) 118 (21): 2795.

https://doi.org/10.1182/blood.V118.21.2795.2795

Published: 2011

Journal Articles

Acquired Molecular Defects in Spliceosome Machinery: Novel Pathogenetic Pathways in Myeloid Leukemogenesis

Hideki Makishima, MD, PhD, Hirotoshi Sakaguchi, MD, Valeria Visconte, PhD, Andres Jerez, MD, Anna M Jankowska, PhD, Kathryn M Guinta, Hideki Muramatsu, MD, PhD, Mikkael A Sekeres, MD, Seiji Kojima, MD, PhD, Ramon V. Tiu, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 271.

https://doi.org/10.1182/blood.V118.21.271.271

Published: 2011

Journal Articles

Pathogenesis of MONOSOMY 7 In BONE MARROW FAILURE SYNDROMES

Hideki Makishima, MD, PhD, Fabiola Traina, MD, PhD, Anna M Jankowska, PhD, Yuka Sugimoto, MD, PhD, Kathryn M Guinta, Hirotoshi Sakaguchi, MD, Christine L. O'Keefe, PhD, Hideki Muramatsu, MD, PhD, Seiji Kojima, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 2411.

https://doi.org/10.1182/blood.V118.21.2411.2411

Published: 2011

Journal Articles

Consequences of UTX Dysfunction in Myelodysplastic Syndrome

Anna M Jankowska, PhD, Hadrian Szpurka, PhD, Venugopalan Cheriyath, PhD, Kwok Peng Ng, PhD, Zhenbo Hu, MD, Michael A McDevitt, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 2427.

https://doi.org/10.1182/blood.V118.21.2427.2427

Published: 2011

Journal Articles

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Hideki Makishima, MD, PhD, Shahper N Khan, PhD, Anna M Jankowska, PhD, Yuka Sugimoto, MD, Zhenbo Hu, MD, Venugopalan Cheriyath, PhD, Reda Mahfouz, MD, Quteba Ebrahem, MD, Sergei Vatolin, PhD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2011) 118 (21): 228.

https://doi.org/10.1182/blood.V118.21.228.228

Published: 2011

Journal Articles

Spliceosome GENE MUTATIONS ARE Also PRESENT In the Diverse Mutational Spectrum of CHRONIC Myelomonocytic LEUKEMIA

Hideki Makishima, MD, PhD, Anna M Jankowska, PhD, Valeria Visconte, PhD, Ramon V. Tiu, MD, Kathryn M Guinta, Hadrian Szpurka, PhD, Yuka Sugimoto, MD, PhD, Christine L. O'Keefe, PhD, Alan F. List, MD, Mikkael A Sekeres, MD, Michael A McDevitt, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 1402.

https://doi.org/10.1182/blood.V118.21.1402.1402

Published: 2011

Journal Articles

Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS

Fabiola Traina, MD, PhD, Anna M Jankowska, PhD, Valeria Visconte, PhD, Yuka Sugimoto, MD, PhD, Hadrian Szpurka, PhD, Hideki Makishima, MD, PhD, Andres Jerez, MD, Christine L. O'Keefe, PhD, Mikkael A. Sekeres, MD, MS, Anjali S. Advani, MD, Yogen Saunthararajah, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Sara T. Olalla Saad, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, Ramon V. Tiu, MD

Blood (2011) 118 (21): 461.

https://doi.org/10.1182/blood.V118.21.461.461

Published: 2011

Journal Articles

Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

Blood (2011) 118 (21): 457.

https://doi.org/10.1182/blood.V118.21.457.457

Published: 2011

Journal Articles

Mechanisms of Defective Hydroxylation of 5-Methylcytosine in MDS Include Pathways Other Than TET2 and IDH1/2

Anna M Jankowska, PhD, Yun Huang, PhD, Myunggon Ko, PhD, Utz J Pape, PhD, Hideki Makishima, MD, PhD, Hadrian Szpurka, PhD, Fabiola Traina, MD, PhD, Valeria Visconte, PhD, Ramon V Tiu, MD, Mikkael A Sekeres, MD, Anjana Rao, PhD, Jaroslaw P Maciejewski, MD, PhD

Blood (2011) 118 (21): 462.

https://doi.org/10.1182/blood.V118.21.462.462

Published: 2011

Journal Articles

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX , EZH2 , and DNMT3A

Anna M. Jankowska, Hideki Makishima, Ramon V. Tiu, Hadrian Szpurka, Yun Huang, Fabiola Traina, Valeria Visconte, Yuka Sugimoto, Courtney Prince, Christine O'Keefe, Eric D. Hsi, Alan List, Mikkael A. Sekeres, Anjana Rao, Michael A. McDevitt, Jaroslaw P. Maciejewski

Blood (2011) 118 (14): 3932–3941.

https://doi.org/10.1182/blood-2010-10-311019

Published: 2011

Includes: Supplemental data

Journal Articles

CBL , CBLB , TET2 , ASXL1 , and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

Hideki Makishima, Anna M. Jankowska, Michael A. McDevitt, Christine O'Keefe, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Harish Siddaiah, Mohammed Shaik, Hadrian Szpurka, Eric Hsi, Anjali Advani, Ronald Paquette, Jaroslaw P. Maciejewski

Blood (2011) 117 (21): e198–e206.

https://doi.org/10.1182/blood-2010-06-292433

Published: 2011

Includes: Supplemental data

Journal Articles

UTX Mutations and Epigenetic Changes In MDS/MPN and Related Myeloid Malignancies

Hadrian Szpurka, PhD, MSc, Anna M Jankowska, MSc, Bartlomiej Przychodzen, BSc, Zhenbo Hu, MD, PhD, Yogen Saunthararajah, MD, Michael A McDevitt, MD, PhD, Jaroslaw P Maciejewski, MD, PhD

Blood (2010) 116 (21): 121.

https://doi.org/10.1182/blood.V116.21.121.121

Published: 2010

Journal Articles

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

Hideki Muramatsu, Hideki Makishima, Anna M. Jankowska, Heather Cazzolli, Christine O'Keefe, Nao Yoshida, Yinyan Xu, Nobuhiro Nishio, Asahito Hama, Hiroshi Yagasaki, Yoshiyuki Takahashi, Koji Kato, Atsushi Manabe, Seiji Kojima, Jaroslaw P. Maciejewski

Blood (2010) 115 (10): 1969–1975.

https://doi.org/10.1182/blood-2009-06-226340

Published: 2010

Journal Articles

Impact of TET2 mutations On Responsiveness to Demethylating Agents in MDS.

Anna M. Jankowska, MSc, Mohammed Shaik, MD, Heather Cazzolli, Rebecca Ganetzky, B.A, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 1606.

https://doi.org/10.1182/blood.V114.22.1606.1606

Published: 2009

Journal Articles

Involvement of TET2 in Regulation of Epigenetic Silencing in MDS and Related Myeloid Malignancies.

Hadrian Szpurka, PhD, MSc, Anna M. Jankowska, MSc, Kwok Peng Ng, PhD, Joshua R. Clevenger, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 2908.

https://doi.org/10.1182/blood.V114.22.2908.2908

Published: 2009

Journal Articles

TET2 Mutations Are Frequent in RARS-T.

Hadrian Szpurka, PhD, MSc, Anna M. Jankowska, MSc, Hideki Makishima, MD, PhD, Nelli Bejanyan, MD, Eric D. Hsi, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 3794.

https://doi.org/10.1182/blood.V114.22.3794.3794

Published: 2009

Journal Articles

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

Anna M. Jankowska, MSc, Hideki Makishima, MD, PhD, Rebecca D Ganetzky, B.A., Monika Jasek, PhD, Heather Cazzolli, Courtney Prince, B.S., Manuel Afable, R.N., Christine O'Keefe, PhD, Ramon V. Tiu, MD, Heesun J. Rogers, MD, PhD, Eric D. Hsi, MD, Mikkael A. Sekeres, MD, MS, Michael A McDevitt, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 416.

https://doi.org/10.1182/blood.V114.22.416.416

Published: 2009

Journal Articles

Whole Epigenome Pattern Characterization in CMML and Related Monocytoid Malignancies.

Rebecca D Ganetzky, B.A., Anna M. Jankowska, MSc, Courtney Prince, B.S., Mikkael A. Sekeres, MD, MS, Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 599.

https://doi.org/10.1182/blood.V114.22.599.599

Published: 2009

NARROW

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

Defining the Topography of Deletion 5q Using SNP-A Identifies Patients with More Aggressive Disease and Correlates with Additional Lesions

Acquired Molecular Defects in Spliceosome Machinery: Novel Pathogenetic Pathways in Myeloid Leukemogenesis

Pathogenesis of MONOSOMY 7 In BONE MARROW FAILURE SYNDROMES

Consequences of UTX Dysfunction in Myelodysplastic Syndrome

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Spliceosome GENE MUTATIONS ARE Also PRESENT In the Diverse Mutational Spectrum of CHRONIC Myelomonocytic LEUKEMIA

Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS

Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

Mechanisms of Defective Hydroxylation of 5-Methylcytosine in MDS Include Pathways Other Than TET2 and IDH1/2

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX , EZH2 , and DNMT3A

CBL , CBLB , TET2 , ASXL1 , and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

UTX Mutations and Epigenetic Changes In MDS/MPN and Related Myeloid Malignancies

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

Impact of TET2 mutations On Responsiveness to Demethylating Agents in MDS.

Involvement of TET2 in Regulation of Epigenetic Silencing in MDS and Related Myeloid Malignancies.

TET2 Mutations Are Frequent in RARS-T.

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

Whole Epigenome Pattern Characterization in CMML and Related Monocytoid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only